Formation ofN-acyl-phosphatidylethanolamine andN-acylethanolamine (including anandamide) during glutamate-induced neurotoxicity

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Lipids

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF02562333PMID 10419193
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma lipids and lipoproteins in Greenlandic west coast Eskimos.

  2009cited by this paper
• Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans

  2007cited by this paper
• Triglyceride: the forgotten risk factor.

  1998cited by this paper
• Formation of N-acyl-phosphatidylethanolamines and N-acetylethanolamines: proposed role in neurotoxicity.

  1998cited by this paper
• Formation of N-acyl-phosphatidylethanolamines and N-acetylethanolamines: proposed role in neurotoxicity.

  1998cited by this paper
• The effect of test meal monounsaturated fatty acid: saturated fatty acid ratio on postprandial lipid metabolism

  1998cited by this paper
• Anandamide amidohydrolase reacting with 2‐arachidonoylglycerol, another cannabinoid receptor ligand

  1998cited by this paper
• Characterization of Glutamate‐Induced Formation of N‐Acylphosphatidylethanolamine and N‐Acylethanolamine in Cultured Neocortical Neurons

  1997cited by this paper
• Postprandial coagulation factor VII activity: the effect of monounsaturated fatty acids

  1997cited by this paper
• Is the cannabinoid CB1 receptor a 2-arachidonoylglycerol receptor? Structural requirements for triggering a Ca2+ transient in NG108-15 cells.

  1997cited by this paper
• Do high carbohydrate diets prevent the development or attenuate the manifestations (or both) of syndrome X? A viewpoint strongly against

  1997cited by this paper
• Inhibition by 2-arachidonoylglycerol, a novel type of possible neuromodulator, of the depolarization-induced increase in intracellular free calcium in neuroblastoma x glioma hybrid NG108-15 cells.

  1997cited by this paper
• A second endogenous cannabinoid that modulates long-term potentiation

  1997cited by this paper
• Influence of n-3 fatty acid supplementation on the endogenous activities of plasma lipases.

  1997cited by this paper
• Production and physiological actions of anandamide in the vasculature of the rat kidney.

  1997influential reference
• Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells.

  1997cited by this paper
• Anandamide and other N-acylethanolamines in mouse peritoneal macrophages.

  1997cited by this paper
• Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid.

  1997cited by this paper
• n-3 fatty acids and serum lipoproteins: human studies.

  1997cited by this paper
• Dietary fatty acids in human thrombosis and hemostasis.

  1997cited by this paper
• Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases?

  1996cited by this paper
• Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine.

  1996cited by this paper
• Developmental, tissue-specific, and environmental factors regulate the biosynthesis of N-acylphosphatidyl-ethanolamine in cotton (Gossypium hirsutum L.)

  1996cited by this paper
• Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: involvement of Ca(2+)-dependent transacylase and phosphodiesterase activities.

  1996cited by this paper
• Control of arachidonate levels within inflammatory cells.

  1996cited by this paper
• N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation.

  1996cited by this paper
• The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons.

  1996cited by this paper
• Cannabinoid Receptor Agonists Inhibit Glutamatergic Synaptic Transmission in Rat Hippocampal Cultures

  1996cited by this paper
• Postprandial triacylglycerolaemia: the effect of low-fat dietary treatment with and without fish oil supplementation.

  1996cited by this paper
• Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels.

  1996cited by this paper
• n-3 fatty acids and lipoproteins: Comparison of results from human and animal studies

  1996cited by this paper
• Isotope Dilution Mass Spectrometric Measurements Indicate That Arachidonylethanolamide, the Proposed Endogenous Ligand of the Cannabinoid Receptor, Accumulates in Rat Brain Tissue Post Mortem but Is Contained at Low Levels in or Is Absent from Fresh Tissue*

  1996influential reference
• Staurosporine Induces Programmed Cell Death in Embryonic Neurons and Activation of the Ceramide Pathway

  1996cited by this paper
• Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat

  1996cited by this paper
• N-palmitoylphosphatidylethanolamine stabilizes liposomes in the presence of human serum: effect of lipidic composition and system characterization.

  1995cited by this paper
• Effects of omega-3 fatty acids on intravascular lipolysis of very-low-density lipoproteins in humans.

  1995cited by this paper
• Postprandial triacylglycerolaemia--nutritional implications.

  1995cited by this paper
• Metabolism of cottonseed microsomal N-acylphosphatidylethanolamine.

  1995cited by this paper
• Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

  1995cited by this paper
• 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.

  1995cited by this paper
• Glutamate stimulates the formation of N-acylphosphatidylethanolamine and N-acylphosphatidylethanolamine in cortical neurons in culture

  1995cited by this paper
• Occurrence and postmortem generation of anandamide and other long‐chain N‐acylethanolamines in mammalian brain

  1995cited by this paper
• Glutamate stimulates the formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cortical neurons in culture.

  1995cited by this paper
• Formation and inactivation of endogenous cannabinoid anandamide in central neurons

  1994cited by this paper
• New dawn of cannabinoid pharmacology.

  1994cited by this paper
• Postprandial lipoproteins and progression of coronary atherosclerosis.

  1994cited by this paper
• Postprandial lipid metabolism.

  1994cited by this paper
• Postprandial lipoprotein lipase, insulin and gastric inhibitory polypeptide responses to test meals of different fatty acid composition: comparison of saturated, n-6 and n-3 polyunsaturated fatty acids.

  1994cited by this paper
• Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk.

  1994cited by this paper
• Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein.

  1993cited by this paper
• Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans.

  1993cited by this paper
• Excitatory Amino Acid‐Mediated Cytotoxicity and Calcium Homeostasis in Cultured Neurons

  1993cited by this paper
• Postprandial Lipoprotein Metabolism

  1993cited by this paper
• Pretranslational regulation of the expression of the lipoprotein lipase (EC 3.1, l.34) gene by dietary fatty acids in the rat

  1993cited by this paper
• Plasma triglyceride level and mortality from coronary heart disease.

  1993cited by this paper
• Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

  1992cited by this paper
• Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.

  1992cited by this paper
• Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men

  1992cited by this paper
• Long-term supplementation with n-3 fatty acids, I: Effect on blood lipids, haemostasis and blood pressure.

  1992cited by this paper
• Changes in blood lipids and fibrinogen with a note on safety in a long term study on the effects of n−3 fatty acids in subjects receiving fish oil supplements and followed for seven years

  1992cited by this paper
• Effects of n-3 fatty acids on postprandial triacylglycerol and hormone concentrations in normal subjects

  1992cited by this paper
• Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease.

  1991cited by this paper
• The effects of glyceride structure on absorption and metabolism.

  1991cited by this paper
• Peripheral triacylglycerol extraction in the fasting and post-prandial states.

  1991cited by this paper
• Omega-3 fatty acids in health and disease and in growth and development.

  1991cited by this paper
• Quantitative studies of transfer in vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans.

  1991cited by this paper
• The triglyceride controversy: a review of the data.

  1990cited by this paper
• N-acylated glycerophospholipids and their derivatives.

  1990cited by this paper
• Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

  1990cited by this paper
• Divergent lipoprotein responses to fish oils with various ratios of eicosapentaenoic acid and docosahexaenoic acid.

  1990cited by this paper
• Dose-response effects of fish-oil supplementation in healthy volunteers.

  1990cited by this paper
• Development of excitatory amino acid induced cytotoxicity in cultured neurons

  1990cited by this paper
• Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

  1989cited by this paper
• Eicosapentaenoic acid inhibits hepatic production of very low density lipoprotein

  1989cited by this paper
• Plasma triglyceride levels and coronary disease.

  1989cited by this paper
• Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism.

  1988cited by this paper
• Cardiovascular effects of n-3 fatty acids.

  1988cited by this paper
• High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase.

  1987cited by this paper
• Eicosapentaenoic acid inhibits the secretion of triacylglycerol and of apoprotein B and the binding of LDL in Hep G2 cells.

  1987cited by this paper
• Phase behavior of synthetic N-acylethanolamine phospholipids.

  1986cited by this paper
• N-acylethanolamine phospholipid metabolism in normal and ischemic rat brain.

  1986influential reference
• The triglyceride issue: a view from Framingham.

  1986cited by this paper
• Formation and transport of chylomicrons by enterocytes to the lymphatics.

  1986cited by this paper
• Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase.

  1984cited by this paper
• Biosynthesis of N‐Acylethanolamine Phospholipids by Dog Brain Preparations

  1983influential reference
• Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type.

  1983cited by this paper
• The influence of different types of omega 3 polyunsaturated fatty acids on blood lipids and platelet function in healthy volunteers.

  1983cited by this paper
• Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia.

  1983cited by this paper
• Lipid digestion and absorption.

  1983cited by this paper
• Inhibition of permeability-dependent Ca2+ release from mitochondria by N-acylethanolamines, a class of lipids synthesized in ischemic heart tissue.

  1982cited by this paper
• Eicosapentaenoic acid and platelet function in Japanese.

  1980cited by this paper
• Atherogenesis: a postprandial phenomenon.

  1979cited by this paper

• Accumulation of Bioactive Lipid Species in LPS-Induced Neuroinflammation Models Analysed with Multi-Modal Mass Spectrometry Imaging

  2024cites this paper
• Distribution of Dietary Phospholipids in Selected Agri-Foods: Versatile Nutraceutical Ingredients

  2024cites this paper
• Cannabinoids and PPAR Ligands: The Future in Treatment of Polycystic Ovary Syndrome Women with Obesity and Reduced Fertility

  2022cites this paper
• Effects of Endocannabinoids in Pentilenetetrazole Induced Seizures In Mice

  2020cites this paper
• Effects of endocannabinoids in pentylenetetrazole induced seizures in mice

  2020cites this paper
• High-coverage lipidomics for functional lipid and pathway analyses.

  2020cites this paper
• Dietary fatty acids augment tissue levels of n-acylethanolamines in n-acylphosphatidylethanolamine phospholipase D (NAPE-PLD) knockout mice.

  2018cites this paper
• N‐Stearoylethanolamine protects the brain and improves memory of mice treated with lipopolysaccharide or immunized with the extracellular domain of &agr;7 nicotinic acetylcholine receptor

  2017cites this paper
• Metabolism of endocannabinoids.

  2016cites this paper
• Metabolizm endokannabinoidów Metabolism of endocannabinoids

  2016cites this paper
• Characterization of N-Acyl Phosphatidylethanolamine-Specific Phospholipase-D Isoforms in the Nematode Caenorhabditis elegans

  2014cites this paper
• PRECLINICAL DEVELOPMENT OF PHYTOCANNABINOID- AND ENDOCANNABINOID- BASED PHARMACOTHERAPIES FOR THE TREATMENT OF ETHANOL-INDUCED NEURODEGENERATION

  2013cites this paper
• Covalent modification of lipids and proteins in rat hepatocytes and in vitro by thioacetamide metabolites.

  2012cites this paper
• Syntheses and Immunological Detection of Oxidized Lipid-Derived Protein and Phosphatidylethanolamine Modifications

  2011cites this paper
• Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases

  2009cites this paper
• The endocannabinoid anandamide inhibits potassium conductance in rat cortical astrocytes

  2009cites this paper
• Identification of biosynthetic precursors for the endocannabinoid anandamide in the rat brain

  2008influential citation
• Role of cannabinoids and endocannabinoids in cerebral ischemia.

  2008cites this paper
• Antineoplastic and apoptotic effects of cannabinoids. N-acylethanolamines: protectors or killers?

  2008cites this paper
• Cannabinoids and Neuroprotection in Basal Ganglia Disorders

  2007cites this paper
• Cannabis and endocannabinoid modulators: Therapeutic promises and challenges.

  2005cites this paper
• N-acyl phosphatidylethanolamines affect the lateral distribution of cholesterol in membranes.

  2005cites this paper
• Neuroprotection: Glutamate and Endocannabinoids

  2005cites this paper
• Cannabinoids in neurodegeneration and neuroprotection

  2005cites this paper
• The use of cannabinoids in multiple sclerosis

  2005cites this paper
• Involvement of brain‐derived neurotrophic factor in cannabinoid receptor‐dependent protection against excitotoxicity

  2004cites this paper
• Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways

  2004cites this paper
• Effects of N-acylethanolamines on mitochondrial energetics and permeability transition.

  2004cites this paper
• Therapeutic Potential of Cannabinoids in CNS Disease

  2003cites this paper
• Blockade of cannabinoid CB1 receptor function protects against in vivo disseminating brain damage following NMDA‐induced excitotoxicity

  2002cites this paper
• Age‐related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour

  2002cites this paper
• Acute neuronal injury, excitotoxicity, and the endocannabinoid system

  2002cites this paper
• Release of Fatty Acid Amides in a Patient With Hemispheric Stroke: A Microdialysis Study

  2002cites this paper
• Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression.

  2002cites this paper
• N-Myristoylated Phosphatidylethanolamine: Interfacial Behavior and Interaction with Cholesterol.

  2002cites this paper
• Mitochondria as a Pharmacological Target

  2002cites this paper
• Exogenous Anandamide Protects Rat Brain against Acute Neuronal Injury In Vivo

  2001cites this paper
• Anandamide, but not 2‐arachidonoylglycerol, accumulates during in vivo neurodegeneration

  2001cites this paper
• N-Acylphosphatidylethanolamine accumulation in potato cells upon energy shortage caused by anoxia or respiratory inhibitors.

  2001cites this paper
• Accumulation of the anandamide precursor and other N‐acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death

  2001cites this paper
• Gas chromatography–mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture

  2001cites this paper
• Cannabinoid receptor activation and elevated cyclic AMP reduce glutamate neurotoxicity

  2001cites this paper
• The endocannabinoid nervous system: unique opportunities for therapeutic intervention.

  2001cites this paper
• Anandamide degradation and N‐acylethanolamines level in wild‐type and CB1 cannabinoid receptor knockout mice of different ages

  2001cites this paper
• Determination of the Phospholipid Precursor of Anandamide and Other N‐Acylethanolamine Phospholipids Before and After Sodium Azide‐Induced Toxicity in Cultured Neocortical Neurons

  2000cites this paper
• N-Acylethanolamines and precursor phospholipids - relation to cell injury.

  2000cites this paper
• Endocannabinoids: new targets for drug development.

  2000cites this paper
• Spin-label electron spin resonance studies on the mode of anchoring and vertical location of the N-acyl chain in N-acylphosphatidylethanolamines.

  2000cites this paper
• Electrospray ionization mass spectrometric method for the determination of cannabinoid precursors: N-acylethanolamine phospholipids (NAPEs).

  1999cites this paper